SCHEMBL6868909

SCHEMBL6868909

CN(C)c1ccnc(NC2CCC(NC(=O)Cc3ccccc3Br)CC2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.46
MCHR1 Q99705 11/20 0.42
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPK8 P45983 2/20 0.41
CYP2C9 P11712 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
MAPK9 P45984 1/20 0.41
MAPK10 P53779 1/20 0.41
AURKA O14965 1/20 0.40
AURKB Q96GD4 1/20 0.40
ADRA2A P08913 3/20 0.40
HRH1 P35367 2/20 0.40
HTR2B P41595 2/20 0.40
ADRA1A P35348 1/20 0.40
GAA P10253 1/20 0.39
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6868904 1.00 SIGMAR1 (0.46) SIGMAR1MCHR1ALDH1A1L3MBTL1MAPK8
SCHEMBL6457031 0.89 MCHR1 (0.43) SIGMAR1MCHR1MAPK8MAPK9MAPK10
SCHEMBL6457021 0.89 MCHR1 (0.43) SIGMAR1MCHR1MAPK8MAPK9MAPK10
SCHEMBL6874855 0.88 ALDH1A1 (0.41) SIGMAR1MCHR1ALDH1A1L3MBTL1MAPK8
SCHEMBL6874860 0.88 ALDH1A1 (0.41) SIGMAR1MCHR1ALDH1A1L3MBTL1MAPK8
SCHEMBL6456613 0.87 SIGMAR1 (0.48) SIGMAR1MCHR1ALDH1A1L3MBTL1CDK2
SCHEMBL6456622 0.87 SIGMAR1 (0.48) SIGMAR1MCHR1ALDH1A1L3MBTL1CDK2
SCHEMBL6874044 0.85 AURKA (0.50) SIGMAR1MCHR1ALDH1A1MAPK8CYP2C9
SCHEMBL6874037 0.85 AURKA (0.50) SIGMAR1MCHR1ALDH1A1MAPK8CYP2C9
SCHEMBL6877723 0.82 MCHR1 (0.42) MCHR1MAPK8CYP2C9CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed